Actively Recruiting
Studying Clinical Pharmacogenomic Testing in Adults Receiving Routine Care at the University of Chicago Medical Center
Led by University of Chicago · Updated on 2026-03-04
1200
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying how to collect and use DNA samples from patients who receive regular healthcare at the University of Chicago. The study aims to identify genetic differences that could influence the risk of side effects or benefits from certain medications. The project focuses on patients with various conditions including heart diseases, autoimmune disorders, inflammatory diseases, blood coagulation disorders, hepatitis C, and non-metastatic cancer. Participants in this observational study include adults receiving routine outpatient care, particularly those taking prescription medications or likely to need them soon. DNA samples will be tested for pharmacogenomic markers, and the results will be shared with the patients treating physicians. The study tracks whether this genetic information affects medication decisions in usual healthcare. Participants provide DNA samples and their healthcare is monitored over time to see how pharmacogenomic data is used. The main outcome measured is how feasible it is to include pharmacogenomic testing in routine care over five years. Researchers also observe if having this genetic information changes drug choices. Patients usual care continues throughout the study, which lasts several years.
CONDITIONS
Brief Title
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Research Team
1
1200 Patients Project Study Team
C
Cancer Clinical Trials Office
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
